The University of North Florida Materials Science and Engineering Research Facility (MSERF) has partnered with TESCAN, a leading manufacturer of electron and light microscopes, in the installation of one of its new Q-Phase microscopes, a unique instrument for quantitative phase imaging based on holographic microscopy.
The Q-Phase microscope is a one-of-a-kind holographic microscope capable of imaging live cells for up to five days. Traditional light microscopy of cells requires staining and chemical treatments that capture the state of the cell in time but kills the cell in the process. This new technology allows cells to be imaged while living over the course of days.
“The partnership with TESCAN affords the University the ability to gather cutting-edge data from the latest high-tech equipment” said Dr. Paul Eason, UNF-MSERF director and associate professor of mechanical engineering in the College of Computing, Engineering and Construction.
The agreement between the University and TESCAN provides UNF the opportunity to house brand new and unique microscopes for the purpose of instrument validation and demonstration for potential users. The Q-Phase microscope, housed at MSERF in the newly renovated Skinner-Jones Hall, is on the UNF campus for a 90-day trial installation.
Researchers both at UNF and the Mayo Clinic are taking advantage of the trial installation and utilizing the high-powered device in their respective studies of treating various types of cancer.
Image Credit: AZO Nano
News This Week
Omicron subvariant BA.2 – which was dominant worldwide early this year, including in Hong Kong – replicates more swiftly than other strains and causes faster programmed cell death in human brains, a new study has found. [...]
The urgent need to remove excess carbon dioxide from Earth’s environment could include enlisting some of our planet’s smallest inhabitants, according to an international research team led by Michael Hochella of the Department of [...]
Blood pressure is a key vital sign that provides insight into our cardiovascular health. But blood pressure is typically measured only a few times per year by a clinician—and these measurements might not always [...]
A South African laboratory study using Covid-19 samples from an immunosupressed individual over six months showed that the virus evolved to become more pathogenic, indicating that a new variant could cause worse illness than [...]
For the past several months, Omicron subvariants BA.4 and BA.5 have dominated COVID-19 cases in the U.S. But now, there’s a class of new COVID subvariants on the rise and one in particular is getting plenty of [...]
Nucleic acid therapies involving DNA or RNA have significant potential to treat genetic disorders, infectious diseases, and cancer; however, research suggests that less than 1% of injected nucleic acid doses reach target cells in [...]
The US Food and Drug Administration on Tuesday approved Hemgenix, a new drug to treat hemophilia. Manufacturer CSL Behring set the price at $3.5 million per treatment, making it the most expensive drug [...]
Some wounds just won’t heal. Infections, diseases like diabetes, and suppressed immune systems often stack up to slow healing. Chronic wounds can last months and lead to anxiety and depression. In the worst cases, [...]